Home›People›Jee Shin
Jee Shin

Jee Shin

Founder and Chief Business Officer, director at Calyxo. Also a chief executive officer and director at Nob Hill Therapeutics.

ExecutiveDirectorRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Apr 16, 2026·Suggest an edit

About Jee Shin

Jee Shin is a founder and chief business officer, director at Calyxo.

Form D filings also name Jee Shin as a chief executive officer and director at Nob Hill Therapeutics.

Jee Shin first appears on SEC filings in 2016.

Experience

This experience comes from Jee Shin's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jee Shin in the role, so the role may have started earlier or lasted longer.

Calyxo, Inc. Current
Founder and Chief Business Officer, director
2016 – Present · Pleasanton, CA
Calyxo makes a kidney stone removal system for urologists.
VIC Technology Venture Development
Managing Director
2014 – 2019
Nob Hill Therapeutics, Inc.
CEO (2016 – 2018)
Director
2016 – 2018 · Albuquerque, NM
Revision Optics
Board Member
2010 – 2012
Zosano Pharma
Board Member
2008 – 2012
ProQuest Investments
Principal
2001 – 2012
Immune Design
Board Observer
2010 – 2011
Excaliard Pharmaceuticals, Inc.
Board Observer
2009 – 2011
Cadence Pharmaceuticals
Board Observer
2005 – 2006
Situs Corporation
Director of Marketing and Business Development
1998 – 2001
Johnson & Johson Medical, Inc.
Surgical Specialties Representative
1994 – 1996

Key Colleagues at Startups

The people Jee Shin works with at each company, as listed on that company's latest Form D.

Calyxo, Inc. · Form D, Apr 16, 2026
Douglas Hughes
Douglas Hughes
Chief Financial Officer and director
Joe Catanese
Joe Catanese
President and Chief Executive Officer, director
JG
DA
Dave Amerson
Director
Ryan Drant
Ryan Drant
Founder and Managing Partner, director
Chris Buchko
Chris Buchko
Chief Administrative Officer
DM
Dana Mead
Director
Nob Hill Therapeutics, Inc. · Form D/A, Apr 25, 2018
RG
R. Goforth
Director
MK
Mark Kidd
Executive officer

Sources

  1. SECCalyxo, Inc. Form D, filed Apr 16, 2026
  2. SECNob Hill Therapeutics, Inc. Form D/A, filed Apr 25, 2018